Robust take following exposure to vaccinia virus: Case definition and guidelines of data collection, analysis, and presentation of immunization safety data

Vaccine

Volumn 25, Issue 31, 2007, Pages 5763-5770

  Graham, Philip L ^a,b   LaRussa, Philip S ^a   Kohl, Katrin S ^c  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Adverse event; Case definition; Guidelines; Immunization; Robust take; Smallpox vaccine; Vaccinia virus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; VACCINIA VACCINE;

ARTICLE; BACTERIAL INFECTION; CLINICAL FEATURE; CLINICAL TRIAL; DECISION MAKING; DRUG EXPOSURE; DRUG SAFETY; ECZEMA; ECZEMA VACCINATUM; HUMAN; IMMUNIZATION; IMPETIGO; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE INFECTION; INJECTION SITE PAIN; LYMPHADENOPATHY; LYMPHANGITIS; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRESSIVE VACCINIA; SKIN MANIFESTATION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; SUPERINFECTION; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; VACCINIA; VACCINIA VIRUS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; IMMUNIZATION; SAFETY; SMALLPOX VACCINE; TERMINOLOGY; VACCINIA; VACCINIA VIRUS;

EID: 34447291120     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.063     Document Type: Article

References (24)

1. World Health Organization. Declaration of global eradication of smallpox. Wkly Epidemiol Rec 1980;55:148.
2. Henderson D.A. About the first national symposium on medical and public health response to bioterrorism. Emerg Infect Dis 5 (1999) 492-493
3. Shalala D. Bioterrorism; how prepared are we?. Emerg Infect Dis 5 (1999) 492-493
4. Russel P.K. Vaccines in civilian defense against bioterrorism. Emerg Infect Dis 5 (1999) 531-533
5. Frey S.E., Newman F.K., Cruz J., Shelton W.B., Tennant J.M., Polach T., et al. Dose-related effects of smallpox vaccine. N Engl J Med 346 (2002) 1275-1280
6. Frey S.E., Couch R.B., Tacket C.O., Treanor J.J., Wolff M., Newman F.K., et al. Clinical responses to undiluted and diluted smallpox vaccine. N Eng J Med 346 (2002) 1265-1274
7. Frey S.E., Newman F.K., Yan L., and Belshe R.B. Response to smallpox vaccine in persons immunized in the distant past. JAMA 289 (2003) 3295-3299
8. Kohl K.S., Gidudu J., Bonhoeffer J., Braun M.M., Michael Buettcher M., Chen R.T., et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine 25 (2007) 5671-5674
9. Centers for Disease Control and Prevention. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR 2006;55(No. RR-1):1-16.
10. CDC. Vaccinia (smallpox) vaccine recommendations of the advisory committee on immunization practices (ACIP), 2001. MMWR 2001;50(RR10);1-25. Report available on the world wide web: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5010a1.htm [last accessed February 9, 2006].
11. CDC. Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR 2003;52(RR-4):1-28. Available on the world wide web: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5204a1.htm [last accessed February 9, 2006].
12. Fulginity V.A., Papier A., Lane M., Neff J.M., and Henderson D.A. Smallpox vaccination: a review, Part II, adverse events. CID 37 (2003) 251-271
13. Plaut M., and Tinkle S.S. Editorial: risks of smallpox vaccination: 200 years after Jenner. J Allergy Clin Immunol 112 (2003) 683-685
14. Aragon T.J., Ulrich S., Fernyak S., and Rutherford G.W. Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968. BMC Public Health 3 (2003) 26-38
15. Lane J.M., Ruben F.L., Neff J.M., and Millar J.D. Complications of smallpox vaccination 1968 results of ten statewide surveys. J Infect Dis 122 4 (1970) 303-309
16. Neff J.M., Lane J.M., Pert J.H., Moore R., Millar J.D., and Henderson D.A. Complications of smallpox vaccination. Part I. National survey in the United States, 1963. N Engl J Med 276 3 (1967) 125-132
17. Simon P.A., Chen R.T., Elliott J.A., and Schwartz B. Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccination. Pediatr Infect Dis J 12 (1993) 368-371
18. Stetler H.C., Garbe P.L., Dwyer D.M., Facklam R.R., Orenstein W.A., West G.R., et al. Outbreaks of group A streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccination. Pediatrics 75 (1985) 299-303
19. Vellozzi C., Averhoff F., Lane J.M., Wen X., Moore A.C., Santibanez S., et al. Superinfection following smallpox vaccination (vaccinia), United States: Surveillance January 2003 through January 2004. CID 39 (2004) 1660-1666
20. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). Guidelines for clinical safety assessment (E2a-e). Available on the worldwide web: http://www.ich.org/ [last accessed February 9, 2006].
21. Council for International Organizations of Medical Sciences (CIOMS). Reporting form for international reporting of adverse drug reactions. Available on the worldwide web: http://www.cioms.ch/frame-what-is-cioms.htm [last accessed February 9, 2006].
22. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987-91. Available on the worldwide web: http://www.consort-statement.org/Statement/revisedstatement.htm [last accessed February 9, 2006].
23. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet. 1999 Nov 27;354(9193):1896-900. Available on the worldwide web: http://www.consort-statement.org/Initiatives/complements.htm [last accessed February 9, 2006].
24. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008-12. Available on the worldwide web: http://www.consort-statement.org/Initiatives/complements.htm [last accessed February 9, 2006].